Literature DB >> 16736236

L-DOPA inhibits depolarization-induced [3H]GABA release in the dopamine-denervated globus pallidus of the rat: the effect is dopamine independent and mediated by D2-like receptors.

I Silva1, H Cortes, E Escartín, C Rangel, L Florán, D Erlij, J Aceves, B Florán.   

Abstract

The effect of L-DOPA on [(3)H]GABA release in slices of globus pallidus from 6-OHDA-lesioned rats was studied. Release was evoked by high (15 mM) K(+). The lesion reduced dopamine content and dopamine synthesized from L-DOPA. The inhibition of DOPA decarboxylase blocked dopamine synthesis. Endogenous dopamine released by high K(+) inhibited [(3)H]GABA release in normal but not in lesioned slices. L-DOPA inhibited (IC(50) = 0.44 microM) evoked [(3)H]GABA release. The inhibition was via D2-like receptors but not mediated by dopamine. The turning behavior induced by L-DOPA methyl ester (25 mg/kg, i.p.) was not abolished by the DOPA decarboxylase inhibitor 3-hydroxybenzylhydrazine but in this condition it was abolished by sulpiride. Results suggest that L-DOPA acting as D2-like agonist inhibits GABA release in the rat globus pallidus and induces turning behavior in rats with unilateral lesions of the dopamine innervation. L-DOPA could control Parkinson's disease symptoms acting not only as dopamine precursor but also by itself.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736236     DOI: 10.1007/s00702-006-0493-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum.

Authors:  A Lopez; A Muñoz; M J Guerra; J L Labandeira-Garcia
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

2.  Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats.

Authors:  Y Takeuchi; T Sawada; S Blunt; P Jenner; C D Marsden
Journal:  Brain Res       Date:  1991-10-25       Impact factor: 3.252

3.  Cellular localization and expression of the serotonin transporter in mouse brain.

Authors:  D Bengel; O Jöhren; A M Andrews; A Heils; R Mössner; G L Sanvitto; J M Saavedra; K P Lesch; D L Murphy
Journal:  Brain Res       Date:  1997-12-19       Impact factor: 3.252

4.  Behavioral activity and stereotypy in rats induced by L-DOPA metabolites: a possible role in the adverse effects of chronic L-DOPA treatment of Parkinson's disease.

Authors:  Taizo Nakazato; Akitane Akiyama
Journal:  Brain Res       Date:  2002-03-15       Impact factor: 3.252

5.  Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.

Authors:  J Opacka-Juffry; S Ashworth; R G Ahier; S P Hume
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

6.  A cumulative dose-response technique for the characterization of presynaptic receptors modulating [3H]noradrenaline release from rat brain slices.

Authors:  A L Frankhuyzen; A H Mulder
Journal:  Eur J Pharmacol       Date:  1982-02-19       Impact factor: 4.432

7.  Biphasic actions of L-DOPA on the release of endogenous dopamine via presynaptic receptors in rat striatal slices.

Authors:  Y Misu; Y Goshima; T Kubo
Journal:  Neurosci Lett       Date:  1986-12-12       Impact factor: 3.046

8.  Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats.

Authors:  J L Hudson; C G van Horne; I Strömberg; S Brock; J Clayton; J Masserano; B J Hoffer; G A Gerhardt
Journal:  Brain Res       Date:  1993-10-29       Impact factor: 3.252

9.  Non-effective dose of exogenously applied L-dopa itself stereoselectively potentiates postsynaptic D2 receptor-mediated locomotor activities of conscious rats.

Authors:  S Nakamura; J L Yue; Y Goshima; T Miyamae; H Ueda; Y Misu
Journal:  Neurosci Lett       Date:  1994-03-28       Impact factor: 3.046

10.  Commonly used L-amino acid decarboxylase inhibitors block monoamine oxidase activity in the rat.

Authors:  S A Treseder; S Rose; L Summo; P Jenner
Journal:  J Neural Transm (Vienna)       Date:  2003-03       Impact factor: 3.575

View more
  3 in total

Review 1.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

Authors:  M G Morgese; T Cassano; S Gaetani; T Macheda; L Laconca; P Dipasquale; L Ferraro; T Antonelli; V Cuomo; A Giuffrida
Journal:  Neurochem Int       Date:  2008-11-01       Impact factor: 3.921

3.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.